This announcement is a separate document:
上海昊海生物科技股份有限公司关于自愿披露全资子公司注射用氨基酸交联透明质酸钠凝胶产品获得医疗器械注册证的公告
Shanghai Haohai Biotechnology Co., Ltd. announcement on the voluntary disclosure of its wholly-owned subsidiary's cross-linked sodium hyaluronate gel for injection product obtaining the medical device registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated